Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo

Detalhes bibliográficos
Autor(a) principal: Helman,Ricardo
Data de Publicação: 2011
Outros Autores: Cançado,Rodolfo Delfini, Olivatto,Cristina
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Einstein (São Paulo)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082011000200160
Resumo: Objective: To identify the incidence of alloimmunization in sickle cell disease patients, as well as autoantibodies and the phenotypic profile of these patients for the following erythrocyte antigen groups: Rh, Kell, Kidd, Duffy and MNS. Methods: fifty-seven patients were evaluated during follow-up at the Anemia Outpatient Clinic of Irmandade da Santa Casa de São Paulo, where a search for irregular antibodies and phenotyping was carried out. Results: Patients’ median alloimmunization age in sickle cell disease was 25 years, and irregular antibodies were found in 22.6% of them. Anti-Kell antibody was the most frequent (7.5%) followed by anti-C (5.7%). Conclusion: The prevalence of alloimmunization and of patients with autoantibodies among individuals with sickle cell disease followed at the Anemia Outpatient Clinic of Irmandade da Santa Casa de Misericórdia de São de Paulo was determined. The risk of alloimmunization was higher in patients who received more than 3 red blood cell units in the past 2 years. The most prevalent alloantibodies were anti-Kell and anti-C.
id IIEPAE-1_b2af1487aa63237be7394805a5962a31
oai_identifier_str oai:scielo:S1679-45082011000200160
network_acronym_str IIEPAE-1
network_name_str Einstein (São Paulo)
repository_id_str
spelling Incidence of alloimunization in sickle cell disease: experience of a center in São PauloAnemia, sickle cell/immunologyBlood transfusionAutoantibodiesBlood group antigens Objective: To identify the incidence of alloimmunization in sickle cell disease patients, as well as autoantibodies and the phenotypic profile of these patients for the following erythrocyte antigen groups: Rh, Kell, Kidd, Duffy and MNS. Methods: fifty-seven patients were evaluated during follow-up at the Anemia Outpatient Clinic of Irmandade da Santa Casa de São Paulo, where a search for irregular antibodies and phenotyping was carried out. Results: Patients’ median alloimmunization age in sickle cell disease was 25 years, and irregular antibodies were found in 22.6% of them. Anti-Kell antibody was the most frequent (7.5%) followed by anti-C (5.7%). Conclusion: The prevalence of alloimmunization and of patients with autoantibodies among individuals with sickle cell disease followed at the Anemia Outpatient Clinic of Irmandade da Santa Casa de Misericórdia de São de Paulo was determined. The risk of alloimmunization was higher in patients who received more than 3 red blood cell units in the past 2 years. The most prevalent alloantibodies were anti-Kell and anti-C.Instituto Israelita de Ensino e Pesquisa Albert Einstein2011-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082011000200160einstein (São Paulo) v.9 n.2 2011reponame:Einstein (São Paulo)instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)instacron:IIEPAE10.1590/s1679-45082011ao2003info:eu-repo/semantics/openAccessHelman,RicardoCançado,Rodolfo DelfiniOlivatto,Cristinaeng2017-03-14T00:00:00Zoai:scielo:S1679-45082011000200160Revistahttps://journal.einstein.br/pt-br/ONGhttps://old.scielo.br/oai/scielo-oai.php||revista@einstein.br2317-63851679-4508opendoar:2017-03-14T00:00Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)false
dc.title.none.fl_str_mv Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
title Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
spellingShingle Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
Helman,Ricardo
Anemia, sickle cell/immunology
Blood transfusion
Autoantibodies
Blood group antigens
title_short Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
title_full Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
title_fullStr Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
title_full_unstemmed Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
title_sort Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo
author Helman,Ricardo
author_facet Helman,Ricardo
Cançado,Rodolfo Delfini
Olivatto,Cristina
author_role author
author2 Cançado,Rodolfo Delfini
Olivatto,Cristina
author2_role author
author
dc.contributor.author.fl_str_mv Helman,Ricardo
Cançado,Rodolfo Delfini
Olivatto,Cristina
dc.subject.por.fl_str_mv Anemia, sickle cell/immunology
Blood transfusion
Autoantibodies
Blood group antigens
topic Anemia, sickle cell/immunology
Blood transfusion
Autoantibodies
Blood group antigens
description Objective: To identify the incidence of alloimmunization in sickle cell disease patients, as well as autoantibodies and the phenotypic profile of these patients for the following erythrocyte antigen groups: Rh, Kell, Kidd, Duffy and MNS. Methods: fifty-seven patients were evaluated during follow-up at the Anemia Outpatient Clinic of Irmandade da Santa Casa de São Paulo, where a search for irregular antibodies and phenotyping was carried out. Results: Patients’ median alloimmunization age in sickle cell disease was 25 years, and irregular antibodies were found in 22.6% of them. Anti-Kell antibody was the most frequent (7.5%) followed by anti-C (5.7%). Conclusion: The prevalence of alloimmunization and of patients with autoantibodies among individuals with sickle cell disease followed at the Anemia Outpatient Clinic of Irmandade da Santa Casa de Misericórdia de São de Paulo was determined. The risk of alloimmunization was higher in patients who received more than 3 red blood cell units in the past 2 years. The most prevalent alloantibodies were anti-Kell and anti-C.
publishDate 2011
dc.date.none.fl_str_mv 2011-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082011000200160
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082011000200160
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/s1679-45082011ao2003
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
publisher.none.fl_str_mv Instituto Israelita de Ensino e Pesquisa Albert Einstein
dc.source.none.fl_str_mv einstein (São Paulo) v.9 n.2 2011
reponame:Einstein (São Paulo)
instname:Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron:IIEPAE
instname_str Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
instacron_str IIEPAE
institution IIEPAE
reponame_str Einstein (São Paulo)
collection Einstein (São Paulo)
repository.name.fl_str_mv Einstein (São Paulo) - Instituto Israelita de Ensino e Pesquisa Albert Einstein (IIEPAE)
repository.mail.fl_str_mv ||revista@einstein.br
_version_ 1752129906197659648